Cited by 810Heart Failure Treatment and ManagementCardiac Fibrosis and RemodelingInflammatory Biomarkers in Disease Prognosis

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure

Rauchhaus, Mathias, Doehner, Wolfram, Francis, Darrel P., Davos, Constantinos, Kemp, Michael, Liebenthal, Christa, Niebauer, Josef, Hooper, James, Volk, Hans-Dieter, Coats, Andrew J. S., Anker, Stefan D.·2000·Circulation

DOI 10.1161/01.cir.102.25.3060

Open this paper in CoChat — free account

Abstract

Background —Inflammatory immune activation is an important feature in chronic heart failure (CHF). Little is known about the prognostic importance of tumor necrosis factor-α (TNF-α), soluble TNF-receptor 1 and 2 (sTNF-R1/sTNF-R2), interleukin-6 (IL-6), and soluble CD14 receptors (sCD14) in CHF patients. Methods and Results —In 152 CHF patients (age 61±1 years, New York Heart Association [NYHA] class 2.6±0.1, peak V̇ o 2 17.3±0.6 mL · kg −1 · min −1 , mean±SEM) plasma concentrations of immune variables were prospectively assessed. During a mean follow-up of 34 months (>12 months in all patients), 62 patients (41%) died. Cumulative mortality was 28% at 24 months. In univariate analyses, increased total and trimeric TNF-α, sTNF-R1, and sTNF-R2 (all P ≤0.0001), sCD14 ( P =0.0007), and IL-6 ( P =0.005) predicted 24-month mortality. With multivariate analysis and receiver operating characteristics, sTNF-R1 emerged among all cytokine parameters as the strongest and most accurate prognosticator in this CHF population, regardless of follow-up duration and independently of NYHA class, peak V̇ o 2 , V̇ e /V̇ co 2 slope, left ventricular ejection fraction, and wasting ( P <0.001). The receiver operating characteristic area under the curve for sTNF-R1 was greater than for sTNF-R2 at 6, 12, and 18 months (all P <0.05). Conclusions —sTNF-R1 was the strongest and most accurate prognosticator, independent of established markers of CHF severity. Assessment of sTNF-R1 may be useful in identifying patients who are at high risk of death and in monitoring patients undergoing anti–TNF-α treatment.

Integrity signals

Registry

Crossref · 10.1161/01.cir.102.25.3060

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The meaning and use of the area under a receiver operating characteristic (ROC) curve.
Hanley, J. A., & McNeil, B. J. (1982) · Radiology · doi:10.1148/radiology.143.1.7063747 · Cited by 21,856
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230405 · Cited by 2,582
Wasting as independent risk factor for mortality in chronic heart failure
Anker, S. D., Ponikowski, P. P., Varney, S. J., Chua, T. P., Clark, A. L., Webb-Peploe, K., Harrington, D., Kox, W. J., Poole-Wilson, P. A., & Coats, A. J. S. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07015-8 · Cited by 1,399
Self-citation
Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)
Torre-Amione, G., Kapadia, S., Benedict, C., Oral, H., Young, J. B., & Mann, D. L. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00589-7 · Cited by 1,211
Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.
Swedberg, K. B., Eneroth, P. H. E., KJEKSHUS, J. K., & Wilhelmsen, L. (1990) · Circulation · doi:10.1161/01.cir.82.5.1730 · Cited by 1,147
Tumor Necrosis Factor-α and Tumor Necrosis Factor Receptors in the Failing Human Heart
Torre‐Amione, G., Kapadia, S. R., Lee, J. J., Durand, J., Bies, R. D., Young, J. B., & Mann, D. L. (1996) · Circulation · doi:10.1161/01.cir.93.4.704 · Cited by 991
Endotoxin and immune activation in chronic heart failure: a prospective cohort study
Niebauer, J., Volk, H.-D., Kemp, M., Dominguez, M., Schumann, R. R., Rauchhaus, M., Poole-Wilson, P. A., Coats, A. J., & Anker, S. D. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09286-1 · Cited by 877
Self-citation
Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia
Anker, S. D., Chua, T. P., Ponikowski, P., Harrington, D., Swan, J. W., Kox, W. J., Poole-Wilson, P. A., & Coats, A. J. S. (1997) · Circulation · doi:10.1161/01.cir.96.2.526 · Cited by 800
Self-citation
Mechanisms and Models in Heart Failure
Mann, D. L. (1999) · Circulation · doi:10.1161/01.cir.100.9.999 · Cited by 769
Plasma Brain Natriuretic Peptide as an Indicator of Left Ventricular Systolic Function and Long-term Survival After Acute Myocardial Infarction
Omland, T., Aakvaag, A., Bonarjee, V., Caidahl, K., Lie, R. T., Nilsen, D. W. T., Sundsfjord, J., & Dickstein, K. (1996) · Circulation · doi:10.1161/01.cir.93.11.1963 · Cited by 698

Show all 27 references

Research works printed but not linked: 7

10.1161/circ.96.2.526 · DOI
10.1161/circ.92.6.1479 · DOI
10.1161/circ.93.4.704 · DOI
10.1161/circ.82.5.2225374 · DOI
10.1161/circ.93.11.1963 · DOI
10.1161/circ.99.25.3224 · DOI
10.1161/circ.100.9.999 · DOI

Sorted by citations

Items 501–600 of 810

The admission level of CRP during cardiogenic shock is a strong independent risk marker of mortality
Roubille, F., Cherbi, M., Kalmanovich, E., Delbaere, Q., Bonnefoy‐Cudraz, E., Puymirat, É., Schurtz, G., Gerbaud, É., Bonello, L., Lim, P., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-67556-y · Cited by 15
Pulmonary Hypertension and Right Ventricle: A Pathophysiological Insight
Namazi, M., Eftekhar, S. P., Mosaed, R., Dini, S. S., & Hazrati, E. (2024) · Clinical Medicine Insights Cardiology · doi:10.1177/11795468241274744 · Cited by 15
The Current and Potential Clinical Relevance of Heart Failure Biomarkers
Gandhi, P. U., Testani, J. M., & Ahmad, T. (2015) · Current Heart Failure Reports · doi:10.1007/s11897-015-0268-2 · Cited by 15
Whole blood transcriptomic profiling identifies molecular pathways related to cardiovascular mortality in heart failure
Nath, M., Romaine, S. P. R., Koekemoer, A. L., Hamby, S. E., Webb, T. R., Nelson, C. P., Castellanos‐Uribe, M., Papakonstantinou, M., Anker, S. D., Lang, C. C., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2540 · Cited by 15
Self-citation
NGAL and other markers of inflammation as competitive or complementary markers for depressive symptom dimensions in heart failure
Naudé, P. J. W., Mommersteeg, P. M. C., Gouweleeuw, L., Eisel, U. L. M., Denollet, J., Westerhuis, L. W. J. J. M., & Schoemaker, R. G. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1062550 · Cited by 15
Immune status evaluation of patients with chronic heart failure
Myrianthefs, P. M., Lazaris, N., Venetsanou, K., Smigadis, N., Karabatsos, E. G., ANASTASIOU‐NANA, M. I., & Baltopoulos, G. J. (2007) · Cytokine · doi:10.1016/j.cyto.2007.03.007 · Cited by 16
Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function
Medenwald, D., Dietz, S., Tiller, D., Kluttig, A., Greiser, K. H., Loppnow, H., Thiery, J., Nuding, S., Russ, M., Fahrig, A., et al. (2014) · Open Heart · doi:10.1136/openhrt-2013-000004 · Cited by 15
Innate inflammation in myocardial perfusion and its implication for heart failure
Picano, E., Morales, M. A., Ry, S. D., & Sicari, R. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05724.x · Cited by 15
TNFα antagonist upregulates interleukin-6 in rats with hypertensive heart failure
Haugen, E., Täng, M. S., Isic, A., Andersson, B., & Fu, M. L. X. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.08.047 · Cited by 15
Biventricular Versus Right Ventricular Pacing Decreases Immune Activation and Augments Nitric Oxide Production in Patients with Chronic Heart Failure
Rubaj, A., Ruciński, P., Rejdak, K., Oleszczak, K., Duma, D., Grieb, P., & Kutarski, A. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.12.001 · Cited by 15
Pro-Inflammatory Cytokines and Cardiac Extracellular Matrix: Regulation of Fibroblast Phenotype
Brown, R. D., Mitchell, M. D., & Long, C. S. (2005) · Springer eBooks · doi:10.1007/0-387-22825-x_3 · Cited by 15
Soluble TNF-α and Interleukin-6 Receptors in the Urine of Heart Failure Patients. Their Clinical Value and Relationship with Plasma Levels
Rivera, M., Taléns‐Visconti, R., Sirera, R., Bertoméu, V., Salvador, A., Cortés, R., de Burgos, F. G., Climent, V. E., Payá, R., Martínez‐Dolz, L., et al. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2004.03.017 · Cited by 15
The pathophysiology of heart failure
McDonagh, T. A., & Dargie, H. J. (2022) · Oxford University Press eBooks · doi:10.1093/med/9780198766223.003.0013 · Cited by 14
Beneficial Effects of Pitavastatin, a 3-Hydroxy-3-Methylglutaryl Coenzyme a Reductase Inhibitor, on Cardiac Function in Ischemic and Nonischemic Heart Failure
Aoyagi, T., Nakamura, F., Tomaru, T., & Toyo‐oka, T. (2008) · International Heart Journal · doi:10.1536/ihj.49.49 · Cited by 14
Soluble Tumor Necrosis Factor Receptor 1 Is Strongly and Independently Associated With Serum Homocysteine in Nonobese Japanese Type 2 Diabetic Patients
Taniguchi, A., Fukushima, M., Nakai, Y., Ohgushi, M., Kuroe, A., Ohya, M., & Seino, Y. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc06-0037 · Cited by 14
Salt intake is associated with inflammation in chronic heart failure.
Azak, A., Huddam, B., Gonen, N., Yilmaz, S. R., Koçak, G., & Duranay, M. (2014) · PubMed Central · Cited by 14
Interleukin-6 and tumor necrosis factor-α as biochemical markers of heart failure: a head-to-head clinical comparison with B-type natriuretic peptide
Boffa, G., Zaninotto, M., Sartor, R., Mion, M. M., Berton, A., Pasqualetto, C., Razzolini, R., & Plebani, M. (2009) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32832ce8e2 · Cited by 14
Is there a C-reactive protein value beyond which one should consider infection as the cause of acute heart failure?
Pereira, J. C., Ribeiro, A., Ferreira‐Coimbra, J., Barroso, I., Guimarães, J. T., Bettencourt, P., & Lourenço, P. (2018) · BMC Cardiovascular Disorders · doi:10.1186/s12872-018-0778-4 · Cited by 14
Body Mass Index and Outcomes in Patients With Heart Failure
Curtis, J. P., Selter, J. G., Wang, Y., Rathore, S. S., Jovin, I. S., Jadbabaie, F., Kosiborod, M., Portnay, E. L., Sokol, S. I., Bader, F. M., et al. (2005) · Cited by 14
The endotoxin-lipoprotein hypothesis – an update
Sandek, A., Utchill, S., & Rauchhaus, M. (2008) · Cited by 14
Self-citation
Nuclear factor-kappaB activity in peripheral blood mononuclear cells in cachectic and non-cachectic patients with chronic heart failure
Siednienko, J., Jankowska, E. A., Banasiak, W., Gorczyca, W. A., & Ponikowski, P. P. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.03.095 · Cited by 14
Metabolic syndrome, insulin resistance, and atherosclerosis in Japanese type 2 diabetic patients
Taniguchi, A., Fukushima, M., Kuroe, A., Sakaguchi, K., Hashimoto, H., Yoshioka, I., Kitatani, N., Tsuji, T., Ohya, M., Ohgushi, M., et al. (2007) · Metabolism · doi:10.1016/j.metabol.2006.07.027 · Cited by 14
Zytokine bei Herzerkrankungen
Rauchhaus, M., & M�ller-Werdan, U. (2001) · Der Internist · doi:10.1007/s001080050726 · Cited by 14
Self-citation
Heart Failure with Preserved Ejection Fraction: a Pharmacotherapeutic Update
Vaz-Salvador, P., Adão, R., Vasconcelos, I., Leite-Moreira, A. F., & Brás‐Silva, C. (2022) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07306-8 · Cited by 15
Reversible heart failure: the role of inflammatory activation
Robinson, T., Smith, A. H., & Channer, K. S. (2010) · Postgraduate Medical Journal · doi:10.1136/pgmj.2010.100123 · Cited by 13
Cardiac Cachexia: Pathophysiology and Clinical Implications
Steinborn, W., & Anker, S. D. (2003) · Cited by 13
Self-citation
Diaphragm Involvement in Heart Failure: Mere Consequence of Hypoperfusion or Mediated by HF-Related Pro-inflammatory Cytokine Storms?
Spießhoefer, J., Boentert, M., Tuleta, I., Giannoni, A., Langer, D., & Kabitz, H. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01335 · Cited by 13
Impact of changes in body mass index after percutaneous coronary intervention on long-term outcomes in patients with coronary artery disease
Yui, H., Ebisawa, S., Miura, T., Nakamura, C., Maruyama, S., Kashiwagi, D., Nagae, A., Sakai, T., Kato, T., Saigusa, T., et al. (2020) · Heart and Vessels · doi:10.1007/s00380-020-01648-3 · Cited by 13
Dietary Inflammatory Index Is Related to Heart Failure Risk and Cardiac Function: A Case–Control Study in Heart Failure Patients
Moludi, J., Shivappa, N., Alisgharzadeh, S., Hébert, J. R., & Alizadeh, M. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.605396 · Cited by 13
Cardiac cachexia - Up-to-date 2015
Gřiva, M. (2015) · Cor et Vasa · doi:10.1016/j.crvasa.2015.08.003 · Cited by 13
Functional and molecular effects of imidazoline receptor activation in heart failure
Stabile, A. M., Aceros, H., Stockmeyer, K., Abdel‐Rahman, A. A., Noiseux, N., & Mukaddam‐Daher, S. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.01.008 · Cited by 13
Cardiac eccentric remodeling in patients with rheumatoid arthritis
Pascale, V., Finelli, R., Giannotti, R., Coscioni, E., Izzo, R., Rozza, F., Caputo, D., Moscato, P., Iaccarino, G., & Ciccarelli, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-24323-0 · Cited by 13
Cardio-oncology: the new frontier of clinical and preventive cardiology
París, S. C., Tarantini, L., Navazio, A., & Faggiano, P. M. (2020) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2020.1348 · Cited by 13
Effect of Thalidomide on the Skeletal Muscle in Experimental Heart Failure
Vescovo, G., Ravara, B., Angelini, A., Sandri, M., Carraro, U., Ceconi, C., & Libera, L. D. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(02)00022-3 · Cited by 13
TNF and angiotensin type 1 receptors interact in the brain control of blood pressure in heart failure
Żera, T., Ufnal, M., & Szczepanska‐Sadowska, E. K. (2014) · Cytokine · doi:10.1016/j.cyto.2014.10.019 · Cited by 13
The role of interleukin-6 in intracellular signal transduction after chronic β-adrenergic stimulation in mouse myocardium
Dziemidowicz, M., Bonda, T. A., Литвинович, С. Н., Taranta, A., Winnicka, M. M., & Kamiński, K. A. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.89452 · Cited by 13
How Many Medicines Do Patients With Heart Failure Need?
Parmley, W. W. (2001) · Circulation · doi:10.1161/01.cir.103.12.1611 · Cited by 13
Physical performance and maximum tongue pressure associated with oral intake independence: a retrospective study on hospitalized patients with heart failure
Yokota, J., Takahashi, R., Endo, R., Chiba, T., Sasaki, K., & Matsushima, K. (2022) · Scientific Reports · doi:10.1038/s41598-022-21968-w · Cited by 14
Variaciones estacionales de 25 (OH) vitamina D en jóvenes sanos y su asociación con la radiación ultravioleta en Buenos Aires
Costanzo, P., Elías, N., Kleiman-Rubinsztein, J., García-Basavilbaso, N., Piacentini, R. D., & Salerni, H. (2011) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 12
Management of anemia in heart failure
Stamos, T. D., & Silver, M. A. (2010) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283357fe0 · Cited by 12
Factors Associated With Elevated N-Terminal Pro B-Type Natriuretic Peptide Concentrations at the Convalescent Stage and 1-Year Outcomes in Patients With Heart Failure With Preserved Ejection Fraction
Oeun, B., Nakatani, D., Hikoso, S., Kojima, T., Dohi, T., Kitamura, T., Okada, K., Sunaga, A., Kida, H., Yamada, T., et al. (2020) · Circulation Reports · doi:10.1253/circrep.cr-20-0051 · Cited by 12
Addition of Losartan to Angiotensin-Converting Enzyme Inhibitors Improves Insulin Resistance in Patients With Chronic Heart Failure Treated Without .BETA.-Blockers
Oginö, K., Kato, M., Furuse, Y., Kinugasa, Y., Kaetsu, Y., Mizuta, E., Sugihara, S., Ishida, K., Yanagihara, K., Hisatome, I., et al. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0395 · Cited by 12
Role of systemic inflammation in functional recovery, dysphagia, and 1-y mortality in heart failure: A prospective cohort study
Matsuo, H., Yoshimura, Y., Fujita, S., Maeno, Y., & Tanaka, S. (2021) · Nutrition · doi:10.1016/j.nut.2021.111465 · Cited by 12
Pathological role of angiostatin in heart failure: an endogenous inhibitor of mesenchymal stem-cell activation
Yamahara, K., Min, K. D., Tomoike, H., Kangawa, K., Kitamura, S., & Nagaya, N. (2008) · Heart · doi:10.1136/hrt.2008.152223 · Cited by 12
Anemia in Heart Failure
Paul, S. C., & Paul, R. V. (2004) · The Journal of Cardiovascular Nursing · doi:10.1097/00005082-200411001-00008 · Cited by 12
Tumor Necrosis Factor-Alpha in Heart Failure: More Questions Than Answers
Charakida, M., & Halcox, J. (2005) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(06)60724-x · Cited by 12
The carotid body: A novel key player in neuroimmune interactions
Katayama, P. L., Leirão, I. P., Kanashiro, A., Menani, J. V., Zoccal, D. B., Colombari, D. S. A., & Colombari, E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1033774 · Cited by 11
Host-microbe tryptophan partitioning in cardiovascular diseases
Russo, M. A., Garaci, E., Frustaci, A., Fini, M., Costantini, C., Oikonomou, V., Nunzi, E., Puccetti, P., & Romani, L. R. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106994 · Cited by 12
Nutritional Support Reduces Circulating Cytokines in Patients with Heart Failure
Herrera-Martínez, A. D., Jiménez, C. M., Romo, A. N., Aguilera, J. L., Crespín, M. C., Torrecillas-Baena, B., Casado‐Díaz, A., Moreno, M. Á. G., Puerta, M. J. M., & Jurado, A. (2024) · Nutrients · doi:10.3390/nu16111637 · Cited by 12
Positron Emission Tomography in Heart Failure: From Pathophysiology to Clinical Application
Tersalvi, G., Beltrani, V., Grübler, M. R., Molteni, A., Cristoforetti, Y., Pedrazzini, G. B., Treglia, G., & Biasco, L. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10050220 · Cited by 12
Immunologic Network and Response to Intramyocardial CD34+ Stem Cell Therapy in Patients With Dilated Cardiomyopathy
Haddad, F., Sever, M., Poglajen, G., Ležaić, L., Yang, P. C., Maecker, H. T., Davis, M. M., Kuznetsova, T., Wu, J. C., & Vrtovec, B. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.03.011 · Cited by 11
Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: A pilot study
Marín, F. R., Roldán, V., Martı́nez, J. G., Hernández‐Madrid, A., Hernández‐Romero, D., Ortego, M., Ibáñez, A., Marín, I., Navarro, X., Lip, G. Y. H., et al. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.05.022 · Cited by 11
Significance of clinical variables and selected biochemical markers in predicting the outcome of bovine anaplasmosis
El-Ashker, M. R., Salama, M., Sebaei, M. G. E., Risha, E., Abdelhamid, F., El-Diasty, M., & Elfadl, E. A. A. (2015) · Veterinární Medicína · doi:10.17221/8244-vetmed · Cited by 11
Heat tolerance of Fire Service Instructors
Watkins, E., Hayes, M., Watt, P., & Richardson, A. (2019) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2019.03.005 · Cited by 11
Assessing inflammation in Chinese subjects with subtypes of heart failure: an observational study of the Chinese PLA Hospital Heart Failure Registry.
Liu, B., Li, Y., Liu, J., Zhao, X., Qia, J., Liu, C., Xu, Z., & He, K. (2019) · PubMed Central · doi:10.11909/j.issn.1671-5411.2019.04.002 · Cited by 11
URSODEOXYCHOLIC ACID IN PATIENTS WITH CHRONIC HEART FAILURE. A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL
von Haehling, S., Schefold, J. C., Jankowska, E. A., Springer, J., Vazir, A., Kalra, P. R., Sandek, A., Fauler, G., Stojaković, T., Trauner, M., et al. (2012) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2012-8-1-110-117 · Cited by 11
Self-citation
Nourin-Associated miRNAs: Novel Inflammatory Monitoring Markers for Cyclocreatine Phosphate Therapy in Heart Failure
Elgebaly, S. A., Todd, R., Kreutzer, D. L., Christenson, R. H., El-Khazragy, N. N., Arafa, R. K., Rabie, M. A., Mohamed, A. F., Ahmed, L. A., & Sayed, N. S. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073575 · Cited by 11
A Nested Case Control Study of Plasma ICAM-1, E-Selectin and TNF Receptor 2 Levels, and Incident Primary Open-Angle Glaucoma
Kang, J. H., Wiggs, J. L., & Pasquale, L. R. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11191 · Cited by 11
Determinants of maximal exercise performance in chronic heart failure
Senden, P. J., Sabelis, L. W. E., Zonderland, M. L., van de Kolk, R., Meiss, L., de Vries, W. R., Bol, E., & Mosterd, W. L. (2004) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000116825.84388.eb · Cited by 11
Serum markers of apoptosis in the early period of heart transplantation
Sánchez-Lázaro, I. J., Bonet, L. A., Romero-Pelechano, A., Portolés, M., Martínez‐Dolz, L., Roselló‐Lletí, E., González‐Juanatey, J. R., Rivera-Otero, M., & Salvador‐Sanz, A. (2012) · Biomarkers · doi:10.3109/1354750x.2012.664168 · Cited by 11
Comparative symptom biochemistry between moderate and advanced heart failure
Lee, C. S., Denfeld, Q. E., Aouizerat, B. E., Jurgens, C. Y., Chien, C., Aarons, E., Gelow, J. M., Hiatt, S. O., & Mudd, J. O. (2018) · Heart & Lung · doi:10.1016/j.hrtlng.2018.09.002 · Cited by 11
Prognostic role of genetic polymorphisms of the interleukin-6 signaling pathway in patients with severe heart failure
Hansen, P., Nelveg-Kristensen, K., Rasmussen, H., Torp-Pedersen, C., Køber, L., Nielsen, C., & Enevold, C. (2019) · The Pharmacogenomics Journal · doi:10.1038/s41397-019-0068-2 · Cited by 9
Expanded Network of Inflammatory Markers of Atherogenesis: Where Are We Now?
Abbasi, S. H., & Boroumand, M. A. (2010) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401004010038 · Cited by 11
The Syndrome of Cardiac Cachexia
Anker, S. D., & Sharma, R. (2001) · Developments in cardiovascular medicine · doi:10.1007/978-1-4615-1449-7_11 · Cited by 11
Self-citation
Effects of Quinapril on Myocardial Function, Ventricular Remodeling and Cardiac Cytokine Expression in Congestive Heart Failure in the Rat
Ge, W., Sirois, M. G., Qu, R., Liu, P. J., & Rouleau, J. L. (2002) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1015315531157 · Cited by 11
Association between early detection of soluble TNF-receptors and mortality in burn patients
Ribeiro, C. M. F., Andrade, C., Polanczyk, C. A., & Clausell, N. (2002) · Intensive Care Medicine · doi:10.1007/s00134-001-1190-5 · Cited by 11
C-reactive protein in chronic heart failure: A new predictor of survival
Celık, T., Iyısoy, A., Çeli̇k, M., Yüksel, U. Ç., & Kardeşoğlu, E. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.12.116 · Cited by 11
Clinical benefit of combined assessment of physical and psychological frailty in patients with heart failure
Iwatsu, K., Adachi, T., Kamisaka, K., Kamiya, K., Iida, Y., Yamada, S., & collabolators, T. F. (2022) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17769 · Cited by 10
Early pathological mechanisms in a mouse model of heart failure with preserved ejection fraction
Rosas, P. C., Neves, L. A. A., Patel, N. A., Tran, D., Pereira, C. H., Bonilla, K., Zheng, J., Sun, J., Alvarado, F. J., & Banach, K. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00318.2024 · Cited by 11
New and future heart failure drugs
Haghighat, L., DeJong, C., & Teerlink, J. R. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00576-z · Cited by 14
Recent advances on immunity and hypertension: the new cells on the kidney block
Dasinger, J. H., Abais‐Battad, J. M., McCrorey, M. K., & Beusecum, J. P. V. (2025) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00309.2024 · Cited by 10
Initial white blood cell count is an independent risk factor for survival in patients with dilated cardiomyopathy
Riad, A. H., Weitmann, K., Herda, L. R., Empen, K., Gross, S., Nauck, M. A., Dörr, M., Klingel, K., Kandolf, R., Hoffmann, W. U., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.11.061 · Cited by 10
Plasma Cytokine Profile in Tropical Endomyocardial Fibrosis: Predominance of TNF-a, IL-4 and IL-10
Bossa, A. S., Salemi, V. M. C., Ribeiro, S. P., Rosa, D. S., Ferreira, L. R. P., Ferreira, S. C., Nishiya, A. S., Mady, C., Kalil, J. E., & Cunha‐Neto, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108984 · Cited by 10
Increased plasma soluble tumor necrosis factor receptor-1 and myeloperoxidase activity in patients with obstructive sleep apnea syndrome
Hanikoğlu, F., Hüseyinoğlu, N., Özben, S., Çört, A., Özdem, S., & Özben, T. (2014) · International Journal of Neuroscience · doi:10.3109/00207454.2014.960521 · Cited by 10
The concentration of interleukin-33 in heart failure with reduced ejection fraction
Segiet, O. A. (2019) · The Anatolian Journal of Cardiology · doi:10.14744/anatoljcardiol.2019.64614 · Cited by 10
C-reactive protein reduction with sacubitril-valsartan treatment in heart failure patients.
Gonçalves, A. V., Pereira‐da‐Silva, T., Galrinho, A., Rio, P., Branco, L. M., Soares, R. M., Moreira, R. I., & Ferreira, R. C. (2020) · PubMed Central · Cited by 10
Sphingomyelinase activity promotes atrophy and attenuates force in human muscle fibres and is elevated in heart failure patients
Olsson, K., Cheng, A. J., Al‐Ameri, M., Tardif, N., Melin, M., Rooyackers, O., Lanner, J. T., Westerblad, H., Gustafsson, T. P., Bruton, J. D., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13029 · Cited by 10
Serum concentration of visfatin is decreased in patients with chronic heart failure.
Straburzyńska‐Migaj, E., Pilaczyńska-Szczȩśniak, Ł., Nowak, A., Straburzyńska‐Lupa, A., Śliwicka, E., & Grajek, S. (2012) · Acta Biochimica Polonica · doi:10.18388/abp.2012_2118 · Cited by 10
Imbalance of catabolic and anabolic pathways in chronic heart failure
Anker, S. D. (2002) · Scandinavian Journal of Nutrition · doi:10.1080/110264802753704064 · Cited by 10
Self-citation
Cardiorenal Syndrome Type 1
Ronco, C., Lullo, L. D., & McCullough, P. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-44942-7.00111-4 · Cited by 10
Perkutaner Aortenklappenersatz – Pro
Buellesfeld, L., & Grube, E. (2009) · Herz · doi:10.1007/s00059-009-3213-x · Cited by 10
Molecular mechanisms underlying sarcopenia in heart failure
Rutledge, C. A. (2023) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2023.40 · Cited by 9
Gut Microbiota and Short-Chain Fatty Acids in Cardiometabolic HFpEF: Mechanistic Pathways and Nutritional Therapeutic Perspectives
Vacca, A., Brosolo, G., Marcante, S., Mora, S. D., Bulfone, L., Porto, A. D., Pagano, C., Catena, C., & Sechi, L. A. (2026) · Nutrients · doi:10.3390/nu18020321 · Cited by 11
A study of inflammatory markers and their correlation with severity, in patients with chronic heart failure.
Ansari, N., Hasan, A., & Owais, M. (2012) · Biomedical Research-tokyo · Cited by 9
Role of Distinct Macrophage Populations in the Development of Heart Failure in Macrophage Activation Syndrome
Kuna, J., Żuber, Z. M., Chmielewski, G., Gromadziński, L., & Krajewska–Włodarczyk, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052433 · Cited by 9
Levels of TNF-α and Soluble TNF Receptors in Normal-Weight, Overweight and Obese Patients with Dilated Non-Ischemic Cardiomyopathy: Does Anti-TNF Therapy Still Have Potential to Be Used in Heart Failure Depending on BMI?
Lazar-Poloczek, E., Romuk, E. B., Jacheć, W., Stanek, W., Stanek, B., Szołtysik, M., Techmański, T., Hasterok, M., & Wojciechowska, C. (2022) · Biomedicines · doi:10.3390/biomedicines10112959 · Cited by 9
Platelet-to-Albumin Ratio: The Prognostic Utility in the Prediction of 2-Month Postoperative Heart Transplant Complications
Babă, D.-F., Suciu, H., Huma, L., Avram, C., Danilesco, A., Moldovan, D.-A., Opincar, A. S., & Sin, A. I. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10060241 · Cited by 9
Advances in pathogenesis and current therapeutic strategies for cardiorenal syndrome
Du, Y., Li, X., & Liu, B. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.10.003 · Cited by 9
Reactive Oxygen Species (ROS) Signaling in Cardiac Remodeling and Failure
Harvey, A., & Grieve, D. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_50 · Cited by 9
Sleep-Disordered Breathing, Cognitive Functioning, and Adherence in Heart Failure: Linked Through Pathology?
Trupp, R. J., & Corwin, E. J. (2008) · Progress in Cardiovascular Nursing · doi:10.1111/j.1751-7117.2008.08000.x · Cited by 9
Anemia and erythropoietin in heart failure.
van der Meer, P., Lipsic, E., van Gilst, W. H., & van Veldhuisen, D. J. (2008) · PubMed · Cited by 9
Multidimensional Approach of Heart Failure Diagnosis and Prognostication Utilizing Cardiac Imaging with Biomarkers
Kim, I., & Yoo, B. (2022) · Diagnostics · doi:10.3390/diagnostics12061366 · Cited by 10
In Silico Modeling of Fabry Disease Pathophysiology for the Identification of Early Cellular Damage Biomarker Candidates
Gervas‐Arruga, J., Barba-Romero, M. Á., Fernández-Martín, J., Gómez-Cerezo, J. F., Segú-Vergés, C., Ronzoni, G., & Cebolla, J. J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910329 · Cited by 8
The therapeutic potential of Honeysuckle in cardiovascular disease: an anti-inflammatory intervention strategy
Zhao, Y. (2024) · American Journal of Translational Research · doi:10.62347/njmj7853 · Cited by 8
Association between cardiac cachexia and adverse outcomes in patients with heart failure: a meta-analysis of cohort studies
Liu, B., Wu, X., Wang, Y., & Hu, X. (2025) · Heart · doi:10.1136/heartjnl-2024-325431 · Cited by 8
Are There Differences in Acute Phase Inflammation Markers regarding the Type of Heart Failure?
Sánchez-Lázaro, I. J., Bonet, L. A., Regañón, E., Vila, V., Martínez‐Sales, V., Martínez‐Dolz, L., Agüero-Ramón-Llin, J., & Salvador‐Sanz, A. (2011) · Heart International · doi:10.4081/hi.2011.e17 · Cited by 8
The relationship of prognostic nutritional index with prognosis and inflammation in patient with heart failure and reduced ejection fraction
Davran, G. B., Davran, A. Ç., & Karabağ, T. (2022) · Nutrition and Health · doi:10.1177/02601060221103017 · Cited by 8
Plasma Tumour Necrosis Factor-Alpha-Related Proteins in Prognosis of Heart Failure with Pulmonary Hypertension
Sällberg, A. E., Helleberg, S., Ahmed, S., Ahmed, A., & Rådegran, G. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14507 · Cited by 8
Association of weight loss with cardiovascular or all-cause mortality in patients with heart failure: A meta-analysis
Wu, X., Wang, Y., & Hu, X. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01484-9 · Cited by 8
Gut Microbiota-Related Modulation of Immune Mechanisms in Post-Infarction Remodelling and Heart Failure
Roessler, J., Zimmermann, F., Heidecker, B., Landmesser, U., & Haghikia, A. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14991 · Cited by 8

Authors: Rauchhaus, M., Doehner, W., Francis, D. P., Davos, C., Kemp, M., Liebenthal, C., Niebauer, J., Hooper, J., Volk, H.-D., Coats, A. J. S., & Anker, S. D.
Affiliations: Royal Brompton Hospital (GB)
From Clinical Cardiology, National Heart and Lung Institute (M.R., W.D., D.P.F., C.D., J.N., A.J.S.C., S.D.A.), and Biochemistry, Royal Brompton Hospital (M.K., J.H.), London, UK; the Universitätsklinik und Poliklinik für Innere Medizin III, Martin-Luther-Universität (M.R.), Halle, Germany; and the Institut für Medizinische Immunologie, Charité (Campus Mitte) (C.L., H.-D.V.), and Franz-Volhard-Klinik (Charité, Campus Berlin-Buch) am Max-Delbrück Centrum für Molekulare Medizin (S.D.A.),...
ORCID: Doehner, Wolfram
Davos, Constantinos
Niebauer, Josef
Hooper, James
Volk, Hans-Dieter
Coats, Andrew J. S.
Anker, Stefan D.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2000-12-19
Volume: 102
Issue: 25
Pages: 3060-3067
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.102.25.3060
OpenAlex: W2066885413
Cited by: 810
References: 27
Citations by year: 2026: 15 · 2025: 19 · 2024: 25 · 2023: 20 · 2022: 31 · 2021: 24 · 2020: 31 · 2019: 22 · 2018: 26 · 2017: 24 · 2016: 24 · 2015: 24 · 2014: 35 · 2013: 35 · 2012: 35
FWCI: 21.26
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
Keywords: chronic heart failure, plasma cytokines, soluble TNF receptor 1, soluble TNF receptor 2, TNF-α, interleukin-6, soluble CD14, inflammation, mortality prediction, prognostic factors, anti-TNF therapy
MeSH terms: Adult, Aged, Aged, 80 and over, Analysis of Variance, Cardiac Output, Low, Chronic Disease, Female, Humans, Immunoassay, Male, Middle Aged, Prognosis, ROC Curve, Solubility, Tumor Necrosis Factor-alpha, Biomarkers, Antigens, CD, Interleukin-6, Survival Analysis, Cytokines, Receptors, Tumor Necrosis Factor, Lipopolysaccharide Receptors, Receptors, Tumor Necrosis Factor, Type I, Receptors, Tumor Necrosis Factor, Type II

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks